CliffBio
small molecule

MAXIBOLIN

ETHYLESTRENOL

Loss of exclusivity—loss of exclusivity
CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand nameMAXIBOLIN
Active ingredientETHYLESTRENOL
Strength2MG/5ML
Dosage formELIXIR
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MAXIBOLIN patent cliff — loss of exclusivity — | CliffBio